Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis

Epidemiol Infect. 2017 Feb;145(3):600-606. doi: 10.1017/S0950268816002624. Epub 2016 Nov 22.

Abstract

Achromobacter spp. are opportunistic pathogens increasingly recovered from adult patients with cystic fibrosis (CF). We report the characterization of 122 Achromobacter spp. isolates recovered from 39 CF patients by multilocus sequence typing, virulence traits, and susceptibility to antimicrobials. Two species, A. xylosoxidans (77%) and A. ruhlandii (23%) were identified. All isolates showed a similar biofilm formation ability, and a positive swimming phenotype. By contrast, 4·3% and 44·4% of A. xylosoxidans and A. ruhlandii, respectively, exhibited a negative swarming phenotype, making the swimming and swarming abilities of A. xylosoxidans significantly higher than those of A. ruhlandii. A. xylosoxidans isolates from an outbreak clone also exhibited significantly higher motility. Both species were generally susceptible to ceftazidime, ciprofloxacin, imipenem and trimethoprim/sulphamethoxazole and there was no significant difference in susceptibility between isolates from chronic or sporadic infection. However, A. xylosoxidans isolates from chronic and sporadic cases were significantly more resistant to imipenem and ceftazidime than isolates of the outbreak clone.

Keywords: Achromobacter; clinical microbiology; cystic fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Achromobacter / classification
  • Achromobacter / drug effects
  • Achromobacter / isolation & purification*
  • Achromobacter / physiology
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / growth & development
  • Cystic Fibrosis / complications*
  • Gram-Negative Bacterial Infections / microbiology*
  • Humans
  • Locomotion
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • Virulence Factors / analysis*

Substances

  • Anti-Bacterial Agents
  • Virulence Factors